{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:54:11Z","timestamp":1790096051472,"version":"4.0.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1097\/01.bor.0000245721.02512.77","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T15:14:35Z","timestamp":1161184475000},"page":"620-624","source":"Crossref","is-referenced-by-count":96,"title":["Cancer and myositis: new insights into an old association"],"prefix":"10.1097","volume":"18","author":[{"given":"Stuart M","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): A missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00002281-199411000-00007","article-title":"Myositis and malignancy","volume":"6","author":"Callen","year":"1994","journal-title":"Curr Opin Rheumatol"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00002281-200011000-00004","article-title":"The association of malignancy with myositis","volume":"12","author":"Yazici","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.7326\/0003-4819-50-5-1174","article-title":"Dermatomyositis and malignancy: a review of the literature","volume":"50","author":"Williams","year":"1959","journal-title":"Ann Intern Med"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-84-1-68","article-title":"Dermatomyositis and malignancy. A review of the literature","volume":"84","author":"Barnes","year":"1976","journal-title":"Ann Intern Med"},{"key":"R6-10-20210128","first-page":"1855","article-title":"The overall and temporal association of cancer with polymyositis and dermatomyositis","volume":"21","author":"Zantos","year":"1994","journal-title":"J Rheumatol"},{"key":"R7-10-20210128","first-page":"1300","article-title":"Elevated cancer incidence in patients with dermatomyositis: a population based study","volume":"22","author":"Airio","year":"1995","journal-title":"J Rheumatol"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005792-199405000-00004","article-title":"Ovarian cancer in patients with dermatomyositis","volume":"73","author":"Whitmore","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1361.047","article-title":"Cancer-associated myositis: clinical features and prognostic signs","volume":"1051","author":"Ponyi","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","article-title":"Tumor antigen markers for the detection of solid cancers in inflammatory myopathies","volume":"14","author":"Amoura","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archderm.1987.01660320095019","article-title":"Prognostic significance of hypopigmentation in malignant melanoma","volume":"123","author":"Bystryn","year":"1987","journal-title":"Arch Dermatol"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E","article-title":"Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo","volume":"79","author":"Fishman","year":"1997","journal-title":"Cancer"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1073\/pnas.1533209100","article-title":"Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma","volume":"100","author":"Phan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-10-20210128","first-page":"215","article-title":"Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo","volume":"90","author":"Uchi","year":"2006"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1363","article-title":"Autoimmunity and tumor immunity induced by immune responses to mutations in self","volume":"12","author":"Engelhorn","year":"2006","journal-title":"Nat Med"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrc1255","article-title":"Paraneoplastic neurological degenerations: keys to tumour immunity","volume":"4","author":"Albert","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R23-10-20210128","first-page":"2136","article-title":"Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors","volume":"60","author":"Darnell","year":"2000","journal-title":"Cancer Res"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0896-6273(93)90077-5","article-title":"Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system","volume":"11","author":"Buckanovich","year":"1993","journal-title":"Neuron"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1523\/JNEUROSCI.16-03-01114.1996","article-title":"The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies","volume":"16","author":"Buckanovich","year":"1996","journal-title":"J Neurosci"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJM199006283222604","article-title":"Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration","volume":"322","author":"Furneaux","year":"1990","journal-title":"N Engl J Med"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.410270515","article-title":"Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer \u2013 a quantitative western blot analysis","volume":"27","author":"Dalmau","year":"1990","journal-title":"Ann Neurol"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0140-6736(93)92485-C","article-title":"Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies","volume":"341","author":"Darnell","year":"1993","journal-title":"Lancet"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","article-title":"Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients","volume":"42","author":"Peterson","year":"1992","journal-title":"Neurology"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/3315","article-title":"Tumor-specific killer cells in paraneoplastic cerebellar degeneration","volume":"4","author":"Albert","year":"1998","journal-title":"Nat Med"},{"key":"R31-10-20210128","first-page":"925","article-title":"The Jo-1 antibody system in myositis: relationships to clinical features and HLA","volume":"8","author":"Arnett","year":"1981","journal-title":"J Rheumatol"},{"key":"R32-10-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"R34-10-20210128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ijc.21118","article-title":"Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis","volume":"116","author":"Okada","year":"2005","journal-title":"Int J Cancer"},{"key":"R35-10-20210128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1529-0131(200102)44:2<389::AID-ANR58>3.0.CO;2-R","article-title":"The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen","volume":"44","author":"Casciola-Rosen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R36-10-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10067-005-1130-9","article-title":"Prostate cancer underlying acute, definitive dermatomyositis: successful treatment with radical perineal prostatectomy","volume":"25","author":"Tallai","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R37-10-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1442-2042.2005.01105.x","article-title":"Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer","volume":"12","author":"Yoshinaga","year":"2005","journal-title":"Int J Urol"},{"key":"R38-10-20210128","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/01.ju.0000047281.73280.7e","article-title":"Successful treatment of dermatomyositis associated with adenocarcinoma of the prostate after radical prostatectomy","volume":"169","author":"Masuda","year":"2003","journal-title":"J Urol"},{"key":"R39-10-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1346-8138.2005.tb00765.x","article-title":"Relapse of dermatomyositis after 10 years in remission following curative surgical treatment of lung cancer","volume":"32","author":"Mori","year":"2005","journal-title":"J Dermatol"},{"key":"R40-10-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2005.040717","article-title":"Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2{beta} antigen","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R41-10-20210128","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20020186","article-title":"Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells","volume":"196","author":"Howard","year":"2002","journal-title":"J Exp Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00130478-200607000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:20:52Z","timestamp":1785939652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200611000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.bor.0000245721.02512.77","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}